A phase 1 study of the CXCR4 antagonist plerixafor in combination with high‐dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic... von Cooper, Todd M., Sison, Edward Allan Racela, Baker, Sharyn D., Li, Lie, Ahmed, Amina, Trippett, Tanya, Gore, Lia, Macy, Margaret E., Narendran, Aru, August, Keith, Absalon, Michael J., Boklan, Jessica, Pollard, Jessica, Magoon, Daniel, Brown, Patrick A.

Volltext